Acta Scientific Gastrointestinal Disorders (ASGIS)(ISSN: 2582-1091)

Editorial Volume 7 Issue 5

Advancements in Immunotherapy for Gastric Cancer: Unveiling the Potential of PD-L1 Inhibitors

Andrea Palacios Navas*

Department of General Surgery, Hospital Clinica San Francisco, Ecuador

*Corresponding Author: Andrea Palacios Navas, Department of General Surgery, Hospital Clinica San Francisco, Ecuador.

Received: March 22, 2024; Published: April 01, 2024

Abstract

Gastric cancer ranks as the fifth most prevalent cancer globally. While its incidence is declining in the United States, it remains disproportionately high in certain Asian countries, notably Japan, South Korea, and Mongolia [1].

References

  1. American Cancer Society. Stomach (Gastric) Cancer Key Statistics. American Cancer Society (2024).
  2. Narita Y and Muro K. “Updated Immunotherapy for Gastric Cancer – PMC”. (2023).
  3. Iikura Y., et al. “Safety evaluation of fixed‐dose nivolumab in patients with gastric cancer”. Health Science Report (2022).
  4. “Opdivo (nivolumab) dosing, indications, interactions, adverse effects, and more”. Medscape Reference (2017).

Citation

Citation: Andrea Palacios Navas. “Advancements in Immunotherapy for Gastric Cancer: Unveiling the Potential of PD-L1 Inhibitors". Acta Scientific Gastrointestinal Disorders 7.5 (2024): 01-02.

Copyright

Copyright: © 2024 Andrea Palacios Navas. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is June 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US